Your cart is empty
Add prompt packs to continue
This definitive collection of prompts for biotechnologists represents the cutting edge in artificial intelligence tools applied to the life sciences. Designed by experts in content strategy and instructional design, each prompt has been optimized to streamline workflow in laboratories, research centers and bioproduction plants, ensuring exceptional technical precision in writing critical documentation and analyzing complex data. By integrating this repository into their professional practice, biotechnologists will be able to automate repetitive scientific writing tasks, optimize experimental design, and ensure rigorous compliance with international regulations. It is the indispensable resource for professionals seeking to maximize their productivity, reduce human errors and lead technological innovation in a highly competitive global environment.
100 resources included
He acts as a Senior Specialist in Quality Assurance and Biochemical Control with 20 years of experience in the biotechnology industry. Your objective is to design a comprehensive Environmental Monitoring Master Plan (PMMA) for the facilities of [Name of Company or Laboratory], specifically for the areas intended for the production and quality control of [Name of Biological Product or Critical Reagent]. This plan must strictly comply with international Good Manufacturing Practice (GMP) regulations, Annex 1 of the EMA/FDA guidelines and ISO 14644 standards for clean rooms. The design of the plan must be based on a prior Risk Analysis, identifying the critical control points where microbiological or particle contamination represents a danger to the integrity of the product. You must classify the areas according to their criticality: Grade A (aseptic filling and high-risk operations), Grade B (Grade A environment), and Grades C/D (support and preparation areas). For each area, specify the sampling methodology, including: active air monitoring (volumetric samplers), passive monitoring (90mm sedimentation plates), surface sampling (contact plates or swabs) and personnel monitoring (glove prints and clothing sampling at key points such as forearms and torso). The generated document must include detailed tables that define the Alert Limits and Action Limits for microorganisms (CFU) and non-viable particles (0.5 µm and 5.0 µm) in both 'resting' and 'operating' states. Additionally, it establishes the incubation protocol for the culture media used (such as TSA for bacteria and Sabouraud for fungi), specifying temperatures and times (e.g. 20-25°C for 3 days followed by 30-35°C for 2 days). You must also include a critical section on the management of out-of-specification (OOS) results, detailing the investigation process, the phenotypic or genotypic identification of the isolates, and the implementation of corrective and preventive actions (CAPA). Finally, develop a quarterly trend analysis strategy that allows you to evaluate the laboratory's environmental drift. Includes recommendations on the rotation of disinfectants and sporicides based on the findings of the native flora identified in the monitoring. The tone should be technical, regulatory and oriented towards operational excellence in the advanced biotechnology sector.
He acts as a Principal Investigator in Biotechnology with specialization in in vitro toxicology and cell culture optimization. Your objective is to design an exhaustive and rigorous experimental protocol for the execution of 'Direct Cytotoxicity Assays' on the cell line [Name of the Cell Line, e.g. L929 or HeLa], strictly following the guidelines of the ISO 10993-5 standard. This test is critical to evaluate the biocompatibility of [Name of Compound or Medical Device] intended for [Product End Use]. The protocol must detail the sample preparation phase, specifying whether the material will be evaluated in direct contact or through extracts, defining the surface area or weight in relation to the volume of culture medium [Type of Medium, e.g. DMEM or RPMI with 10% FBS]. Includes a section dedicated to standardizing seeding density in plates [Number of wells, e.g. 96 or 24], ensuring that the cells reach a confluency of [Percent Confluence, e.g. 80%] before exposure. Set the negative controls (low-response material such as high-density polyethylene) and positive controls (material with known toxicity). Develops a qualitative observation methodology based on the reactivity scale (0 to 4) according to cell morphology, detecting signs of lysis, vacuolization, detachment and changes in the plasma membrane. Complement this with a specific quantitative method such as the [Quantification Method assay, e.g. MTT, XTT or Neutral Red pickup]. Provides a step-by-step guide to incubation during [Incubation time, e.g. 24, 48 or 72 hours] at 37°C and 5% CO2, and describes in detail the washing procedure and addition of reagents to avoid experimental artifacts. Finally, request a detailed statistical analysis that includes [Statistical Tests, e.g. One-way ANOVA with Tukey's post-hoc or Student's t-test] to determine the significance of the results. The final output should be a professional technical report that includes the determination of the IC50 if applicable, an interpretation of the results based on international acceptance criteria (where a viability of less than 70% indicates a cytotoxic effect) and specific recommendations to optimize the reproducibility of the assay under laboratory conditions under GLP regulations.
He acts as a Senior Bioprocess Engineer with more than 20 years of experience in the optimization of biotechnological plants and large-scale fermentation processes. Your objective is to design a comprehensive technical strategy for the scale-up of a bioprocess intended for the production of [Biological_Product_Name] using [Type_of_Cell_or_Microorganism]. The project consists of moving from a laboratory/pilot scale of [Initial_Volume] liters to an industrial scale of [Final_Volume] liters, ensuring that volumetric productivity and Critical Quality Attributes (CQA) remain constant or improve. First analyze the characterization of the starting system. Defines key engineering parameters, including volumetric mass transfer coefficient (kLa), power per unit volume (P/V), impeller tip speed, and mixing time. Given that the fluid has a behavior [Type_of_Rheology: Newtonian/Non-Newtonian], you must propose the most appropriate empirical correlations (such as those of Cooper, Fernstrom or Van't Riet) to predict the behavior of dissolved oxygen in the destination bioreactor of [Final_Volume] liters. Develop a comparison of scaling criteria. Evaluate the advantages and disadvantages of scaling based on: 1) Keeping kLa constant, 2) Keeping P/V constant, and 3) Keeping gas flow per volume of liquid (vvm) constant. Justify which of these criteria is the most appropriate for [Biological_Product_Name], considering the sensitivity to hydrodynamic stress of [Type_of_Cell_or_Microorganism] and the specific oxygen demand (OUR) observed in the exponential growth phases. Addresses thermal and mass transfer challenges associated with scaling. In the industrial bioreactor, the surface/volume ratio decreases drastically; therefore, design a robust temperature control system that considers the metabolic heat generated by biomass in [Cultivation_Phase]. In addition, it analyzes the impact of the hydrostatic pressure at the base of the tank on the solubility of CO2 and the possible effect of toxicity due to hypercapnia or changes in intracellular pH. Finally, it establishes a process control plan based on Process Analytical Technologies (PAT). Defines the Critical Process Parameters (CPP) that must be monitored in real time, such as redox potential, optical density or exhaust gas composition (exhaust gas analysis) using mass spectrometry. It concludes with a risk matrix that identifies possible points of failure in mixing and the formation of dead zones in the [Final_Volume] liter bioreactor, proposing technical mitigation strategies.